Literature DB >> 28352133

Haematological cancer: Anti-PD-1 therapy with nivolumab after allo-HSCT for Hodgkin lymphoma.

David Killock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28352133     DOI: 10.1038/nrclinonc.2017.50

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma.

Authors:  Charles Herbaux; Jordan Gauthier; Pauline Brice; Elodie Drumez; Loic Ysebaert; Hélène Doyen; Luc Fornecker; Krimo Bouabdallah; Guillaume Manson; Hervé Ghesquières; Reza Tabrizi; Eric Hermet; Julien Lazarovici; Anne Thiebaut-Bertrand; Adrien Chauchet; Hélène Demarquette; Eileen Boyle; Roch Houot; Ibrahim Yakoub-Agha; Franck Morschhauser
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

  1 in total
  1 in total

Review 1.  Cancer immunotherapy of patients with HIV infection.

Authors:  M Gonzalez-Cao; J Martinez-Picado; N Karachaliou; R Rosell; A Meyerhans
Journal:  Clin Transl Oncol       Date:  2018-11-17       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.